Molecular evidence of increased resistance to anti-folate drugs in Plasmodium falciparum in North-East India: a signal for potential failure of artemisinin plus sulphadoxine-pyrimethamine combination therapy
about
Biology, distribution and control of Anopheles (Cellia) minimus in the context of malaria transmission in northeastern IndiaPolymorphism in drug resistance genes dihydrofolate reductase and dihydropteroate synthase in Plasmodium falciparum in some states of IndiaHigh burden of malaria and anemia among tribal pregnant women in a chronic conflict corridor in India.Urban Malaria: Understanding its Epidemiology, Ecology, and Transmission Across Seven Diverse ICEMR Network Sites.Antigenicity of a Bacterially Expressed Triple Chimeric Antigen of Plasmodium falciparum AARP, MSP-311 and MSP-119: PfAMSP-Fu35Evidence of triple mutant Pfdhps ISGNGA haplotype in Plasmodium falciparum isolates from North-east India: An analysis of sulfadoxine resistant haplotype selection.Prevalence of mutations linked to antimalarial resistance in Plasmodium falciparum from Chhattisgarh, Central India: A malaria elimination point of view.Clinical and molecular monitoring of Plasmodium falciparum resistance to antimalarial drug (artesunate+sulphadoxine-pyrimethamine) in two highly malarious district of Madhya Pradesh, Central India from 2012-2014.Antifolate drug resistance: Novel mutations and haplotype distribution in dhps and dhfr from Northeast India.
P2860
Q28076802-999BC47A-7960-4535-9FA3-F89909C1F271Q28125924-3306187B-6342-4DD3-A972-725B576F74B1Q33815135-C9859021-034D-4B0C-A453-1F4DC0DF6779Q36071330-44D18E03-6F54-45E0-8550-5A067D20158FQ36178611-D41F0A0A-5DA2-424F-9F23-5C170A7058ABQ37414092-5FB23547-10BA-47B7-8E17-586E1C4C0CD5Q47107010-99C90A0A-0C84-43F4-8082-2333460FF768Q47995484-9B110549-2E9A-43A2-9DAA-F98EF703C526Q48019011-279DEF87-BE56-4BED-8543-F7BD95C2928E
P2860
Molecular evidence of increased resistance to anti-folate drugs in Plasmodium falciparum in North-East India: a signal for potential failure of artemisinin plus sulphadoxine-pyrimethamine combination therapy
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Molecular evidence of increase ...... imethamine combination therapy
@ast
Molecular evidence of increase ...... imethamine combination therapy
@en
Molecular evidence of increase ...... imethamine combination therapy
@nl
type
label
Molecular evidence of increase ...... imethamine combination therapy
@ast
Molecular evidence of increase ...... imethamine combination therapy
@en
Molecular evidence of increase ...... imethamine combination therapy
@nl
prefLabel
Molecular evidence of increase ...... imethamine combination therapy
@ast
Molecular evidence of increase ...... imethamine combination therapy
@en
Molecular evidence of increase ...... imethamine combination therapy
@nl
P2093
P2860
P921
P3181
P1433
P1476
Molecular evidence of increase ...... imethamine combination therapy
@en
P2093
Anil Prakash
Basanta Kumar Goswami
Bibhas Sarma
Devojit Kumar Sarma
Dibya Ranjan Bhattacharyya
Jagadish Mahanta
Khukumoni Bora
Pradyumna Kishore Mohapatra
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0105562
P407
P50
P577
2014-01-01T00:00:00Z